Distress Syndrome Procollagen Levels in Acute Respiratory Lavage Fluid Angiogenic Activity and Bronchoalveolar Chemokines Correlates with Imbalance in the Expression of CXC

Diffuse alveolar damage is the histopathological hallmark of acute respiratory distress syndrome (ARDS) and is a stereotypic response to a variety of etiologies. Moreover, a significant proportion of ARDS survivors have residual pulmonary fibrosis and compromised pulmonary function. This suggests that the pathogenesis of diffuse alveolar damage that ultimately leads to the chronic fibrosis of ARDS has features of dysregulated repair exemplified by exaggerated intra-alveolar angiogenesis and fibrogenesis (i.e., fibroproliferation and deposition of extracellular matrix), leading to progressive alveolar fibrosis and impaired lung function. We obtained bronchoalveolar lavage fluid (BALF) from patients with ARDS or ventilated control patients and assessed CXC chemokine levels by ELISA. We found an imbalance in the expression of ELR (cid:1) as compared with ELR (cid:2) CXC chemokines from BALF of patients with ARDS as compared with controls. This imbalance correlated with angiogenic activity as assessed by the corneal micropocket assay. Furthermore, these levels correlated with both procollagen I and procollagen III levels in BALF. In contrast, while BALF levels of vascular endothelial growth factor were elevated, vascular endothelial growth factor did not appear to be significantly contributing to the angiogenic activity. These findings suggest that CXC chemokines have an important role in the fibroproliferative phase of ARDS via the regulation of angiogenesis. The Journal of Immunology, 2002, 169: 6515–6521.

[1]  M. Burdick,et al.  ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis. , 2001, American journal of respiratory and critical care medicine.

[2]  D. Thickett,et al.  Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. , 2001, American journal of respiratory and critical care medicine.

[3]  L. Brochard,et al.  Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury. , 2001, The European respiratory journal.

[4]  M. Burdick,et al.  Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint. , 2001, Arthritis and rheumatism.

[5]  M. Burdick,et al.  The CXC Chemokine Receptor 2, CXCR2, Is the Putative Receptor for ELR+ CXC Chemokine-Induced Angiogenic Activity1 , 2000, The Journal of Immunology.

[6]  N. Goldsack,et al.  Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. , 2000, American journal of respiratory and critical care medicine.

[7]  M. Burdick,et al.  IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. , 1999, Journal of immunology.

[8]  J. Stoller,et al.  Pulmonary complications of mechanical ventilation. , 1999, Clinics in chest medicine.

[9]  M. Burdick,et al.  Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. , 1999, Journal of immunology.

[10]  K. Steinberg,et al.  Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. , 1999, Journal of immunology.

[11]  M. Matthay,et al.  The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. , 1999, Critical care medicine.

[12]  F. Stentz,et al.  Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. , 1998, American journal of respiratory and critical care medicine.

[13]  G R Bernard,et al.  The American-European Consensus Conference on ARDS, part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome. , 1998, American journal of respiratory and critical care medicine.

[14]  R. Whyte,et al.  The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. , 1997, Journal of immunology.

[15]  W. Coulson Spencer's Pathology of the Lung , 1997 .

[16]  M. Matthay,et al.  Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance. , 1997, American journal of respiratory and critical care medicine.

[17]  F. Martinez,et al.  Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8. , 1996, Journal of immunology.

[18]  R. Whyte,et al.  Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases , 1996, The Journal of experimental medicine.

[19]  M. Burdick,et al.  Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. , 1996, The Journal of clinical investigation.

[20]  P. Sime,et al.  Mechanisms of Scarring , 1996 .

[21]  Armen B. Shanafelt,et al.  The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*) , 1995, The Journal of Biological Chemistry.

[22]  H. Winer-Muram,et al.  The fibroproliferative phase of late adult respiratory distress syndrome. , 1995, Seminars in respiratory infections.

[23]  K. Steinberg,et al.  Type III Procollagen Peptide in the Adult Respiratory Distress Syndrome: Association of Increased Peptide Levels in Bronchoalveolar Lavage Fluid with Increased Risk for Death , 1995, Annals of Internal Medicine.

[24]  V. Dixit,et al.  Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. , 1994, The American journal of pathology.

[25]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[26]  P. Montravers,et al.  High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome , 1993, Infection and immunity.

[27]  R. Clark Basics of cutaneous wound repair. , 1993, The Journal of dermatologic surgery and oncology.

[28]  C. Henke,et al.  Role of mesenchymal cell death in lung remodeling after injury. , 1993, The Journal of clinical investigation.

[29]  R. Strieter,et al.  Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups , 1993, The Lancet.

[30]  G. Meduri Late adult respiratory distress syndrome. , 1993, New horizons.

[31]  R. Strieter,et al.  Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.

[32]  P. Bitterman Pathogenesis of fibrosis in acute lung injury. , 1992, The American journal of medicine.

[33]  M. Peterson,et al.  Identification and partial characterization of angiogenesis bioactivity in the lower respiratory tract after acute lung injury. , 1991, The Journal of clinical investigation.

[34]  J. McDonald Idiopathic pulmonary fibrosis. A paradigm for lung injury and repair. , 1991, Chest.

[35]  R. Clark,et al.  The commonality of cutaneous wound repair and lung injury. , 1991, Chest.

[36]  J. Tomashefski,et al.  Pulmonary pathology of the adult respiratory distress syndrome. , 1990, Clinics in chest medicine.

[37]  R. Crapo,et al.  Prediction of pulmonary function abnormalities after adult respiratory distress syndrome (ARDS). , 2015, The American review of respiratory disease.

[38]  C. C. Baker,et al.  THE YALE JOURNAL OF BIOLOGY AND MEDICINE 59 (1986), 575-597 The Adult Respiratory Distress Syndrome , 1985 .

[39]  A. Koch,et al.  Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. , 1986, Arthritis and rheumatism.

[40]  J. Tomashefski,et al.  The pulmonary vascular lesions of the adult respiratory distress syndrome. , 1983, The American journal of pathology.